1.She, H., Y. He, Y. Zhao and Z. Mao. Release the autophage brake on inflammation: The MAPK14/p38alpha-ULK1 pedal.Autophagy: (2018)1-2. （IF=8.6）
2.She, H., Y. He, Y. Zhao and Z. Mao. Autophagy in inflammation: the p38alpha MAPK-ULK1 axis. Macrophage . (2018)
3.Tian, Z., Y. Chen, N. Yao, C. Hu, Y. Wu, D. Guo, J. Liu, Y. Yang, T. Chen, Y. Zhao and Y. He（通讯作者）. Role of Mitophagy Regulation by ROS in Hepatic Stellate Cells during Acute Liver Failure. Am J Physiol Gastrointest Liver Physiol. 2018(IF=3.46)
4.Y, H., et al., Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis. Aliment Pharmacol Ther, (2018) 47, 526-532.（IF=8.0）
5.Y. He, H. She, T. Zhang, H. Xu, L. Cheng, M. Yepes, Y. Zhao and Z. Mao. p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1. The Journal of cell biology,(2018) 217, 315-328.（IF 8.3）
6.L. Jin, H. Gao, J. Wang, S. Yang, J. Wang, J. Liu, Y. Yang, T. Yan, T. Chen, Y. Zhao and Y. He（通讯作者）. Role and regulation of autophagy and apoptosis by nitric oxide in hepatic stellate cells during acute liver failure. Liver international ,(2017) 37, 1651-1659.（IF 4.2）
7.YL.He, Jin L, Wang J, Yan Z, Chen T,YingRen Zhao, et al. Mechanisms of fibrosis in acute liver failure. liver international. 2015;35:1877-1885. （IF 4.2）Times cited:14
8.He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World journal of gastroenterology : WJG 2006;12:4788-4793. Times cited:52
9.Chen T, He Y(通讯作者), Liu X, Yan Z, Wang K, Liu H, et al. Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Clinical and experimental medicine 2012;12:159-164. Times cited:47
10.He, Y., J. Zhu, Y. Huang, et al., Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis. Acta Diabetol, 2015. 52(5): p. 959-69. Times cited:13
11.Yingli H, Shumei L, Qian Y, Tianyan C, Yingren Z, Wei C. Proapoptotic IL-18 in patients with chronic hepatitis C treated with pegylated interferon-alpha. Clinical and experimental medicine 2009;9:173-178. Times cited:9
12.He Y, Gao H, Li X, Zhao Y. Psychological Stress Exerts Effects on Pathogenesis of Hepatitis B via Type-1/Type-2 Cytokines Shift toward Type-2 Cytokine Response. PloS one 2014;9:e105530.(IF:3.534) Times cited:7
13.He YL, Zhao YR, Zhang SL, Lin SM, Chen W, Liu JF, et al. Defects in the apoptotic machinery are associated with hepatic damage. Journal of viral hepatitis 2007;14:520-522. Times cited:3
14.He Y, Zhao Y, Zhang S, Chen W, Lin S, Yang Q, et al. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection. Journal of clinical virology 2006;37:282-286.Times cited:12
15.J. Wang, Y. He（并列第一）, D. Jin, J. Liu, J. Zheng, N. Yuan, Y. Bai, T. Yan, Y. Yang, Y. Liu, S. Zhang, Y. Zhao and T. Chen. No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg. Infectious diseases,(2017) 49, 576-583.
16.Jin, L., K. Wang, YL,He（通讯作者）, et al., Genomewide Histone H3 Lysine 9 Acetylation Profiling in CD4+ T Cells Revealed Endoplasmic Reticulum Stress Deficiency in Patients with Acute-on-chronic Liver Failure. Scand J Immunol, 2015. 82(5): p. 452-9
17.Yan T, He Y(并列第一), Li Y, Wang J, Chen T, Yang Y, et al. With Cytometric Bead Assay, the Interleukin-10/HBV DNA Ratio Is an Early Predictor for Response to Interferon-alpha Treatment in Chronic Hepatitis B. Journal of interferon & cytokine research 2015. 35(10): p. 779-84.
18.J. Wang, Y. He, D. Jin, J. Liu, J. Zheng, N. Yuan, Y. Bai, T. Yan, Y. Yang, Y. Liu, S. Zhang, Y. Zhao and T. Chen. No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg. Infectious diseases,(2017) 49, 576-583.
19.Chen T, Wang J, Feng Y, Yan Z, Zhang T, Liu M,Yingli He, et al. Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants? BMC infectious diseases 2013;13:524.Times cited:1
20.Yao L, Li W, She H, Dou J, Jia L, He Y, et al. Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects. The Journal of biological chemistry 2012. Times cited:12
21.Jin Y, Ye F, Shi J, Qiu H, Zhao Y, He Y, Lin S, et al. Hepatitis B virus infection and replication in primary cultured human granulosa cells. Archives of virology 2011;156:1-7. Times cited:4
22.Wang K, Liu H, He Y, Chen T, He Y, Yang Y, Niu Y, et al. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Human immunology 2010. Times cited:15
23.Liu J, Li YQ, Chen TY, Yang Y, Wang K, He YL, et al. The distribution of HBV genotypes and clinical significance in familial clustering in an infected population with unfavorable prognosis. Archives of virology 2008;153:2157-2161. Times cited:9
24.Zhao YR, Gong L, He YL, Liu F, Lu C. Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B. World journal of gastroenterology 2005;11:854-857. Times cited:3
中文文章
1.周辉, 杨淑娟, 朱丽, 任丹凤, 李建洲, 张国妤, 杨瑗, 刘锦锋, 赵英仁, 陈天艳, 乔文, 何英利（通讯作者）. 腹腔置管引流治疗肝硬化大量腹水有效性和安全性的研究. 中国循证医学杂志,(2017), 1140-1144.
2.杨淑娟, 赵英仁, 何英利（通讯作者）. 2017年AGA关于急性肝衰竭诊断和管理指南解读. 中国循证医学杂志,(2017), 1394-1399.
3.何英利, 高珩, 刘锦锋, 杨瑗, 陈天艳, 赵英仁. 微课程在感染病学教学中的应用及体会. 卫生职业教育,(2017), 30-32.
4.高珩, 何英利. 高职护生临床实习前心理健康状况调查及干预对策. 全科护理 2010:1696-1698.
5.何英利, 赵英仁. 不良结局家族聚集性HBV感染的宿主因素研究. 西安交通大学学报（医学版） 2010;3:365.
6.石少亭, 李亚军, 何英利, 刘勇, 宋春霞, 张蓓, et al. 汉族人血小板膜糖蛋白Ⅱb/Ⅲa基因多态性与脑梗死的关系. 中风与神经疾病杂志 2009:674-676.
7.杜粉静, 王凤玲, 何英利. 慢性乙型病毒性肝炎患者焦虑状况及影响因素. 护理学杂志 2008:63-65.
8.陈天艳, 何英利, 赵英仁. 试述生命维持治疗中的伦理学问题. 中国医学伦理学 2007;20:54-55.
9.张勇, 吕毅, 杨晓梅, 李泉源, 史源, 何英利, et al. 犬肝脏及附属管道的应用解剖. 第四军医大学学报 2006;27:2039-2042.
10.何英利, 赵英仁, 高珩, 张树林, 陈芸茹, 刘锦锋, et al. CpG岛的生物信息学预测及甲基化特异性PCR分析技术的建立. 第四军医大学学报 2006;23.
11.何英利, 赵英仁, 高珩, 张树林, 杨瑗, 陈芸茹, et al. 聚集性感染家族内乙型肝炎病毒标志物. 第四军医大学学报 2006;24.
12.何英利, 赵英仁, 张树林, 杨瑗, 刘敏, 金燕, et al. 家族聚集性慢性乙型病毒性肝炎患者PBMC免疫相关的基因表达谱. 细胞与分子免疫学杂志 2006;05.
13.赵英仁, 何英利, 张树林, 杨瑗, 刘敏, 金燕, et al. 家族不良结局乙型肝炎外周血单个核细胞基因表达谱的建立. 中华肝脏病杂志 2005;11.
14.刘芳, 赵英仁, 赵良, 路长, 龚玲, 何英利. 分子吸附再循环系统对肝功能衰竭患者血清单核细胞趋化蛋白-1的影响. 中国实用内科杂志 2005;3:251-252.
15.龚玲, 赵英仁, 何英利, 刘芳, 路长. 乙型肝炎慢性化与CⅡTA基因启动子区多态性的相关性. 第四军医大学学报 2004.
16.李正仪, 石少亭, 陈崴, 何英利, 张玉蓉. FX IIIA 3 种基因多态性与脑血管疾病的关系. 中风与神经疾病杂志 2004;22:100-103.
国际级国内大会发言
1.H. yingLi, C. Tianyan and Z. Yingren. Sofosbuvir-based treatment of acute hepatitis C in patients hemodialysis. hepatology International,(2017) 11, S412.（亚太肝病会议大会发言）
2.何英利，陈天艳，赵英仁。索磷布韦为基础的方案在血透合并丙型肝炎患者的安全性和有效性评估。中华医学会第十六次全国感染病学术会议论文汇编。中华医学会感染病分会/中华医学会肝病分会，2017,6（武汉）（中华肝病会议大会发言）
国际会议壁报
1.Y. L. He and Y. R. Zhao. Nitric Oxide inducing apoptosis and inhibiting autophagy via enhancing Bcl2-Beclin1 interaction in hepatocellular carcinoma. Hepatology,(2016) 64, 251a-252a.（2016年AASLD ）
2.He, Yingli; Jin, Li; Wang, Jiuping. Nitric Oxide induced hepatic stellate cells apoptosis through autophagy inhibition in acute liver failure hepatology 63(1)suppl 1072A-1073A
3.YingLi He, Nitric Oxide inducing apoptosis and inhibiting autophagy via enhancing Bcl2-Beclin1 interaction in hepatocellular carcinoma. hepatology 63(1)suppl 251A-252A
4.YingLi He, Heng G, YingRen Z, Ke W. Psychological Stress, Cortisol and Immune Status in Patients with Chronic Hepatitis B. International Journal of Infectious Diseases 2008;12:E417-E418.
5.He YL, Yan Z, Wang K, Chen TY, Liu M, Ye F, et al. HCV Infection And Advanced Liver Cirrhosis Were Associated Insulin Resistance. Journal of Hepatology 2010;52:S88.
6.Wang K, Liu HL, He YL, Chen TY, Ye F, Liu JF, et al. Correlation Of Circulating TLR1 -10 Expression With Peripheral Blood Mononuclear Cells In Chronic Hepatitis B And Related Liver Failure. Journal of Hepatology 2010;52:S287-S288.
7.Du FJ, Gao H, Wang FL, He YL, Zhao YL. A Study of Anxiety Status and Influencing Factors on Patients with Chronic Hepatitis B. International Journal of Infectious Diseases 2008;12:E417-E417.
